SANTA MONICA, Calif., Oct. 4, 2018 /PRNewswire/ -- PRESS RELEASE -- Modern wellness company dosist has announced its first domestic expansion entering into Florida through a partnership with Surterra Wellness. Currently available only in California, dosist's award-winning products will enter Florida this fall, bringing proprietary dose-controlled devices and targeted formulations to more than 160,000 qualified patients throughout the state.
"Florida has been a leader in establishing its medical cannabis industry, which is accelerating at a rapid pace," said Gunner Winston, CEO of dosist. "dosist's products provide targeted therapeutic solutions which will further empower Florida's patients to naturally manage their own health and happiness."
Since launching in 2016, dosist has been recognized as a disruptor in the health industry, named by Fast Company as one of 2018's Top 10 Most Innovative Companies in the health sector, and described by Time Magazine as "cannabis that could replace pills" on their 25 Best Inventions of 2016 list.
"Not a day goes by where we do not hear life-changing stories from our patients and customers," added Winston. "Our product and education platforms are engineered to take the guesswork out of cannabis treatment and deliver targeted solutions for our patients. We cannot wait to bring this innovation to Florida."
dosist products will be available in Florida starting this fall through its strategic partnership with Surterra Wellness, a market leader in delivering Florida's best cannabis-based natural products.
"Gunner and the team at dosist share our commitment to quality, consistency and building brands patients can trust," said Jake Bergmann, CEO and founder of Surterra Wellness. "This partnership provides greater access and more choices to help Florida patients on their path to wellness."
Patients will be able to access dosist products online at dosist.com and in person at all Surterra Wellness retail locations throughout the state, subject to the Florida Department of Health approval.
